Curanex Provides Business Update In Connection With 2025 Annual Report As Phyto-N Advances Toward Planned IND Submission
(MENAFN - GlobeNewsWire - Nasdaq) Company advances manufacturing, toxicology, patent and regulatory milestones while building a broader pharmaceutical development platform Jericho, New York, March ...
Menafn
via Menafn
Updated 1h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...


